Mental health in transgender individuals: a systematic review

International Review of Psychiatry, Journal Year: 2022, Volume and Issue: 34(3-4), P. 292 - 359

Published: May 19, 2022

Several lines of evidence indicate the prevalence mental health disorders in Transgender (TG) individuals is higher than that cisgender or general population. In this systematic review, we aim to propose a summary some most significant research investigating disorders' among We performed double-blind review using Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting (PRISMA) on PUBMED/MEDLINE SCOPUS, specifically peer-reviewed articles examining status transgender individuals. This did not exclude any based publication date. The last search was February 2022. employed strategy led selection 165 articles. majority these papers presented cross-sectional design with self-reported diagnoses symptoms, signaling amongst TG Individuals. Of reviewed articles, 72 examined mood anxiety disorders; 8 eating 43 suicidal self-harm ideation behaviors; 5 trauma stress-related 10 frequency personality 44 substance use 9 autism spectrum disorder. Finally, 22 studies reported diagnosed co-morbid unspecified disorders. Our findings coincide existing research, which indicates do experience population However, further needed address gaps knowledge.

Language: Английский

---

Health and Health Care Among Transgender Adults in the United States

Annual Review of Public Health, Journal Year: 2021, Volume and Issue: 43(1), P. 503 - 523

Published: Dec. 9, 2021

Transgender (trans) communities in the USA and globally have long organized for health social equity but only recently gained increased visibility within public health. In this review, we synthesize evidence demonstrating that trans adults are affected by disparities physical mental access to care, relative cisgender (nontrans) persons. We draw on theory data situate these their contexts, explicating roles of gender affirmation, multilevel intersectional stigmas, policies reproducing or ameliorating disparities. Until recently, were largely made invisible exclusionary collection practices. highlight importance of, methodological considerations for, collecting inclusive sex data. Moving forward, recommend routine identity data, an emphasis intervention research achieve equity, policy advocacy, investment supporting gender-diverse leadership.

Language: Английский

---

Substance Use in the Transgender Population: A Meta-Analysis

Brain Sciences, Journal Year: 2022, Volume and Issue: 12(3), P. 366 - 366

Published: March 10, 2022

(1) Background: This meta-analysis aimed to assess the relationship between identifying as transgender and substance use. (2) Methods: We searched for relevant studies in PubMed, Scopus, Web of Science, PsycINFO on 21 July 2021. (3) Results: Twenty comparing cisgender people were included this work, accounting a total 2,376,951 participants (18,329 whom transgender). These articles data current tobacco use, use disorder, alcohol lifetime (all) (excluding alcohol), specific substances including cocaine, amphetamines, methamphetamines, ecstasy, stimulants, heroin, opiates, cannabis, marijuana, LSD, hallucinogens, steroids, inhalants, sedatives, Ritalin or Adderall, diet pills, cold medicine, prescription medications, polysubstance, other club drugs, illegal drugs), disorder alcohol). used ORs their 95% CIs state association those variables. The control reference category all cases was cisgender. employed random-effects model. Transgender more likely (odds ratio (OR) = 1.65; CI [1.37, 1.98]), have throughout lives (OR 1.48; [1.30, 1.68]), present 1.79; [1.54, 2.07]). When general tobacco, alcohol, disorders specifically considered, likelihood did not differ from that people. (4) Conclusions: presence Considering population consumers addicted may be prejudice perpetuates stigma. Nonetheless, substances, but alcohol. Hypothetically, might an emotional regulation strategy, maladaptive mechanism coping with traumatic experiences, could respond minority stress, produced by stigma, prejudice, discrimination, harassment. It is particular importance implement policies against discrimination stigmatisation adapt prevention treatment services so they are inclusive 2SLGBTQIA+ community.

Language: Английский

---

Disparities in health condition diagnoses among aging transgender and cisgender medicare beneficiaries, 2008-2017

Frontiers in Endocrinology, Journal Year: 2023, Volume and Issue: 14

Published: March 13, 2023

Introduction The objective of this research is to provide national estimates the prevalence health condition diagnoses among age-entitled transgender and cisgender Medicare beneficiaries. Quantification burden across sex assigned at birth gender can inform prevention, research, allocation funding for modifiable risk factors. Methods Using 2009–2017 fee-for-service data, we implemented an algorithm that leverages diagnosis, procedure, pharmacy claims identify beneficiaries stratify sample by inferred gender: trans feminine nonbinary (TFN), masculine (TMN), unclassified. We selected a 5% random individuals comparison. descriptively analyzed (means frequencies) demographic characteristics (age, race/ethnicity, US census region, months enrollment) used chi-square t-tests determine between- (transgender vs. cisgender) within-group differences (e.g., TMN, TFN, unclassified) difference in demographics (p<0.05). then logistic regression estimate examine within- between-group predicted probability 25 conditions, controlling age, enrollment length, region. Results analytic included 9,975 (TFN n=4,198; TMN n=2,762; unclassified n=3,015) 2,961,636 (male n=1,294,690, female n=1,666,946) majority samples were between ages 65 69 White, non-Hispanic. largest proportion from South. On average, had more than individuals. In adjusted models, aging TFN or highest each studied relative males females. all other groups. Discussion These findings document disparities key Future application these methods will enable study rare anatomy-specific conditions hard-to-reach populations interventions policies address documented disparities.

Language: Английский

---

Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs

Substance Abuse Treatment Prevention and Policy, Journal Year: 2024, Volume and Issue: 19(1)

Published: Jan. 3, 2024

Abstract Background Lesbian, gay, bisexual, transgender, queer, and other LGBTQ populations (LGBTQ+; e.g., asexual individuals) have higher rates of substance use (SU) disorders (SUD) compared to heterosexual cisgender populations. Such disparities can be attributed minority stress, including stigma discrimination in healthcare settings. LGBTQ+-affirming SU treatment related services remain limited. The purpose this exploratory qualitative descriptive study was characterize LGBTQ+ people’s experiences recommendations for LGBTQ+- affirming care. Methods We conducted demographic surveys (characterized using statistics) individual interviews with N = 23 people. employed flexible coding a thematic analysis approach describe participants’ stigma, discrimination, support within at the patient-, staff-, organizational-level; participant how make such LGBTQ+-affirming. highlighted components stress mitigators adverse responses throughout our analysis. Results Patient-level included bullying, name-calling, sexual harassment, physical distancing from peers; via community-building peers. Staff-level denial services, misgendering, lack intervention peer assumptions about sexuality; staff advocacy patients, holistic models, openly staff. Organizational-level binary gendered program structures; programs gender-affirming groups housing, visual cues (e.g., rainbow flags) Stigma led processes like identity concealment coping relapse; facilitated engagement retention. Recommendations care non-discrimination policies, LGBTQ+-specific programming, hiring staff, routine sensitivity training, gender-inclusive structures. Conclusions people experience services; supportive is vital reducing barriers promoting positive health outcomes. current offers concrete deliver care, which could reduce drug overdose mortality overall.

Language: Английский

---

Differences in All-Cause Mortality Among Transgender and Non-Transgender People Enrolled in Private Insurance

Demography, Journal Year: 2022, Volume and Issue: 59(3), P. 1023 - 1043

Published: May 12, 2022

Abstract Few studies have analyzed mortality rates among transgender (trans) populations in the United States and compared them to of non-trans populations. Using private insurance data from 2011 2019, we estimated age-specific all-cause a subset trans people enrolled 10% randomly selected cohort. Overall, found that were nearly twice as likely die over period their counterparts. When stratifying by gender, key disparities within populations, with on feminine nonbinary spectrum being at greatest risk males females. While masculine similar overall females, rate was statistically smaller than males. These findings provide evidence some experience substantially different conditions across life course necessitate further study.

Language: Английский

---

Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data

British Journal of General Practice, Journal Year: 2023, Volume and Issue: 73(732), P. e486 - e492

Published: June 5, 2023

Background Transgender and gender diverse (TGD) individuals experience an incongruence between their assigned birth sex identity. They may have a higher prevalence of health conditions associated with cancer risk than cisgender people. Aim To examine the several factors among TGD compared individuals. Design setting A cross-sectional analysis was conducted using data from UKs Clinical Practice Research Datalink to identify 19882020, matched 20 men women on index date (date diagnosis incongruence), practice, age (age at date). Assigned determined gender-affirming hormone use procedures, sex-specific diagnoses documented in medical record. Method The each factor calculated ratio by identity estimated log binomial or Poisson regression models adjusted for year study entry, obesity where appropriate. Results There were 3474 transfeminine (assigned male birth) individuals, 3591 transmasculine female 131 747 men, 827 women. Transmasculine people had highest (27.5%) ever smoking (60.2%). Transfeminine dyslipidaemia (15.1%), diabetes (5.4%), hepatitis C infection (0.7%), B (0.4%), HIV (0.8%). These estimates remained elevated populations persons multivariable models. Conclusion Multiple are more prevalent Future research should how minority stress contributes increased this population.

Language: Английский

---

Examining general, physical, and mental health disparities between transgender and cisgender adults in the U.S.

International Journal for Equity in Health, Journal Year: 2025, Volume and Issue: 24(1)

Published: Feb. 4, 2025

Language: Английский

---

Identifying Intersecting Factors Associated with Suicidal Thoughts and Behaviors among Transgender and Gender Diverse Adults: A Preliminary Conditional Inference Tree Analysis (Preprint)

Journal of Medical Internet Research, Journal Year: 2025, Volume and Issue: 27, P. e65452 - e65452

Published: March 6, 2025

Background Transgender and gender diverse (TGD) individuals are disproportionately impacted by suicidal thoughts behaviors (STBs), intersecting demographic psychosocial factors may contribute to STB disparities. Objective We aimed identify associated with increased risk for ideation, intent, plan, attempts in the US transgender population health survey (N=274), determine age of onset each outcome using conditional inference trees (CITs), which iteratively partitions subgroups greater homogeneity respect a specific outcome. Methods In separate analyses, we restricted variables those typically available within electronic medical records (EMRs) then included not EMRs. also compared results CIT analyses logistic regressions Cox proportional hazards models. Results younger adults endorsed more frequent ideation planning. Adults aged ≤26 years who identified as Black or another race listed had highest followed White, Latine, multiracial ≤39 sexual minority individuals. suicide Increased intent was observed among multiracial, whereas no were previous attempts. EMR-specific identity, such that women older men nonbinary when they first experienced ideation; attempts, than men. expanded including additional variables, psychiatric distress High combined high care stereotype threat linked Only everyday discrimination lifetime Ages identity intersection drug use planning, alone No variable set. The analysis traditional comparable ordinal outcomes, but CITs substantially outperformed outcomes. Conclusions this preliminary test approach TGD risk, primarily influenced age, racial well distress, threat, discrimination. Identifying STBs is vital early detection This should be tested on larger scale EMR data facilitate service provision at STBs.

Language: Английский

---

Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults

Drug and Alcohol Dependence, Journal Year: 2021, Volume and Issue: 223, P. 108711 - 108711

Published: April 20, 2021

Language: Английский

---